Dimerix (ASX:DXB) acquires Phase 2-ready DMX-652 for US$5m upfront, adding an acute kidney injury program and a 2027 catalyst to its pipeline.
17
Stocks in Spotlight
View all →-
Growth Stocks · Financials Powerhouse Ventures (ASX:PVL) Merchant Model Delivers 22x and 240% Deal Wins July 15, 2026 -
AI Stocks · International Stocks SK hynix (NSDQ:SKHY) Surges 27% as Investors Reprice Its 58% HBM Leadership July 15, 2026 -
Financials · Growth Stocks Powerhouse Ventures (ASX:PVL) Builds a Merchant Revenue Engine as CIO Fund Scales July 3, 2026
